Yoshiharu Motoo Selected Research

Yoshiharu Motoo Research Topics

Disease

38	Neoplasms (Cancer) 07/2023 - 10/2002
19	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 10/2002
9	Chronic Pancreatitis 07/2007 - 01/2002
6	Pancreatitis 01/2007 - 03/2002
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2006
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2019 - 01/2006
5	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2005
5	Prostatic Neoplasms (Prostate Cancer) 09/2017 - 10/2002
4	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 01/2006
3	Inflammation (Inflammations) 07/2023 - 11/2009
3	Anorexia 06/2022 - 10/2015
3	Fatigue 06/2022 - 10/2015
3	Peripheral Nervous System Diseases (PNS Diseases) 06/2022 - 06/2020
3	Obesity 09/2020 - 03/2010
3	Neoplasm Metastasis (Metastasis) 12/2017 - 11/2011
3	Adenocarcinoma of Lung 12/2017 - 12/2007
3	Fibrosis (Cirrhosis) 11/2014 - 10/2002
3	Liver Neoplasms (Liver Cancer) 12/2009 - 01/2006
3	Pathologic Constriction (Stenosis) 01/2006 - 01/2005
3	Pancreatic Diseases (Pancreatic Disease) 08/2005 - 10/2002
2	Peritoneal Neoplasms 01/2022 - 12/2017
2	Non-alcoholic Fatty Liver Disease 09/2021 - 09/2020
2	Body Weight (Weight, Body) 09/2021 - 01/2007
2	Disease Progression 06/2021 - 11/2003
2	Anemia 10/2015 - 07/2005
2	Neutropenia 04/2015 - 04/2012
2	Multiple Myeloma 12/2012 - 06/2011
2	Glioblastoma (Glioblastoma Multiforme) 03/2012 - 12/2009
2	Hyperthermia 09/2010 - 10/2009
2	Glucose Intolerance 03/2010 - 11/2009
2	Carcinogenesis 12/2009 - 08/2007
2	Type 2 Diabetes Mellitus (MODY) 12/2009 - 01/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2009 - 11/2009
2	Autoimmune Pancreatitis 01/2008 - 08/2005
2	Anaphylaxis (Anaphylactic Shock) 12/2007 - 08/2007
2	Carcinoma (Carcinomatosis) 12/2006 - 11/2003
2	Thyroid Neoplasms (Thyroid Cancer) 09/2005 - 11/2003
1	Cachexia 06/2022
1	Myalgia 05/2022
1	Mucositis 05/2022
1	Arthralgia (Joint Pain) 05/2022
1	Ascites 01/2022
1	Choline Deficiency 09/2021
1	Exsanguination 09/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2003
8	Gemcitabine FDA Link 04/2015 - 03/2006
8	Nuclear Proteins (Protein, Nuclear)IBA 01/2013 - 07/2004
6	Messenger RNA (mRNA)IBA 06/2012 - 10/2002
5	SteroidsIBA 10/2019 - 10/2002
5	Docetaxel (Taxotere)FDA Link 09/2017 - 10/2009
5	Phosphotransferases (Kinase)IBA 01/2013 - 01/2006
5	Glycogen Synthase KinasesIBA 01/2013 - 01/2006
4	ninjin'yoeitoIBA 06/2022 - 10/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2020 - 10/2015
3	PlatinumIBA 10/2017 - 04/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2012 - 08/2007
3	Therapeutic UsesIBA 03/2012 - 01/2002
3	Glycogen Synthase Kinase 3 betaIBA 12/2009 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 01/2003
3	EnzymesIBA 08/2005 - 10/2002
2	liu-jun-zi-tangIBA 06/2022 - 05/2022
2	juzentaihotoIBA 06/2022 - 01/2013
2	Plant ExtractsIBA 06/2022 - 07/2006
2	bu-zhong-yi-qi-tangIBA 06/2022 - 05/2022
2	gosha-jinki-ganIBA 06/2022 - 05/2022
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022 - 12/2017
2	LipidsIBA 09/2020 - 03/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 01/2005
2	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 03/2011
2	saiko-keishi-to (TJ10)IBA 11/2014 - 01/2007
2	CytokinesIBA 01/2013 - 10/2010
2	Bortezomib (Velcade)FDA Link 12/2012 - 06/2011
2	Tumor Biomarkers (Tumor Markers)IBA 12/2012 - 04/2004
2	Glycogen Synthase (Synthase I)IBA 03/2012 - 11/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012 - 12/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 10/2010
2	Tyrosine (L-Tyrosine)FDA Link 01/2011 - 11/2009
2	MicroRNAs (MicroRNA)IBA 01/2011 - 01/2010
2	imidazole mustard (BIC)IBA 01/2011 - 01/2010
2	Monoclonal AntibodiesIBA 12/2010 - 01/2003
2	Pancreatitis-Associated ProteinsIBA 01/2007 - 03/2003
1	FructoseIBA 07/2023
1	Toll-Like Receptor 4IBA 07/2023
1	Glucose (Dextrose)FDA LinkGeneric 07/2023
1	shakuyaku-kanzoh-tohIBA 05/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	cabozantinibIBA 01/2022
1	ZonarolIBA 09/2021
1	Methionine (L-Methionine)FDA Link 09/2021
1	Choline (Choline Chloride)IBA 09/2021
1	MedetomidineIBA 09/2020
1	Ketamine FDA LinkGeneric 09/2020

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 05/2022 - 12/2007
18	Therapeutics 01/2023 - 01/2005
9	Kampo Medicine (Kampo) 06/2022 - 03/2010
4	Radiotherapy 01/2013 - 01/2011
2	Castration 09/2017 - 03/2011
1	Acupuncture Therapy 09/2020